Expert Insights on Pharmaceutical Industry

The Pharmaceutical Industry is the business sector typically encompassing the production and use of small molecule drugs derived from chemical sources. These substances are aimed at treating, curing, preventing, or recognizing disease.

Gerson Lehrman Group Council Members are available to discuss Pharmaceutical Industry via phone consultations, live meetings, surveys, and other custom GLG products and services.

Find, engage, and manageSM experts today through the GLG platform

Featured Council Members

GLG Council Members are leading experts including academics, scientists, and industry specialists

Gregory Glover, Partner, Pharmaceutical Law Group PC

Gregory GloverWhat is a GLG Educator?|GLG Educators have qualified for GLG Member Programs and are therefore eligible to participate in ongoing in-depth consulting projects with GLG clients.

PartnerPharmaceutical Law Group PC

Gregory Glover, Partner, Pharmaceutical Law Group PC

Gregory GloverWhat is a GLG Educator?|GLG Educators have qualified for GLG Member Programs and are therefore eligible to participate in ongoing in-depth consulting projects with GLG clients.

PartnerPharmaceutical Law Group PC

Kuldeepak Sharma, President/Pharmaceutical Consultant, Dr. Kuldeepak Sharma

Kuldeepak Sharma What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

President/Pharmaceutical ConsultantDr. Kuldeepak Sharma

Kuldeepak Sharma, President/Pharmaceutical Consultant, Dr. Kuldeepak Sharma

Kuldeepak Sharma What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

President/Pharmaceutical ConsultantDr. Kuldeepak Sharma

Jim Farley, President, Cardinal Consulting and Training

Jim Farley What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

PresidentCardinal Consulting and Training

Browse all 364 Leading Experts

Study Groups

Study groups are populations of experts knowledgeable on specific sub-topics within a broader industry

Study Group Name No. Members
Pharmaceutical Regulation and FDA Experts: Lawyers 49
Pharmaceutical and Biotechnology Experts: Lawyers (US) 53
Pharmaceutical and Biotechnology Experts: Lawyers (EU) 82
Pharmaceutical & Biotechnology Experts (Mexico and South America) 248
Pharmaceutical and Biotechnology Experts: Lawyers (UK) 30

Browse all 981 Study Groups

Recent Live Meetings

Interactive roundtables, private visits, and small scale seminars are types of GLG Live Meetings

June 8, 2010 | Webcast

Webcast: Pharmaceutical Pricing (10:30 AM EDT / 15:30 BST)

February 18, 2010 | Webcast

Webcast: An Auditor's View of Pharmaceutical Manufacturing (11:00 AM EST/ 8:00 AM PST)

March 30, 2010 | Webcast

Webcast: Structural Changes in the Global Pharmaceutical Market: The Role of India (5:00 PM HKT)

May 26, 2010 | Webcast

Webcast: Pharmaceutical and Biotechnology Manufacturing and Supply Chain Management (11:00 AM EDT)

February 16, 2011 | Webcast

Webcast: Pharmaceutical Opportunities in India – Is it Rural? (8:00 AM EST / 13:00 GMT)

Browse all 384 Live Meetings

Recent News Analyses

News analyses are expert commentaries on current events, written by Council Members who are available for follow up consultations

Pharmaceutical Liability: None for generic Drug Manufacturers?

June 28, 2011

Martin Alpert, Vice President, Environmental Claims, HINZ CLAIM MANAGEMENT INC

False paradigm - why embryonic stem cell research is a misnomer

July 6, 2011

GLG Expert Contributor

Sun Pharmaceuticals Industries could show Pharma's new course

July 5, 2011

GLG Expert Contributor

Browse all 8743 GLG News Analyses

Contact Gerson Lehrman Group to engage a Pharmaceutical Industry expert